Lucid Diagnostics ( ($LUCD) ) has provided an update. On April 11, 2025, Lucid Diagnostics Inc. announced the closing of its public offering of ...

Lucid Diagnostics (LUCD) intends to offer shares of common stock through an underwritten public offering. The company also plans to grant the underwriters a 45- ...

GRI Bio, Inc.’s GRI shares plummeted 36.9% on April 1 after the company announced the pricing of a public offering of stock ...

Delinea Inc., a cybersecurity company controlled by TPG Inc., is exploring an initial public offering, according to people with knowledge of the matter. The San Francisco-based company hired ...

In this February post, I pondered the question of whether an issuer could allocate shares on the basis of race, gender or ethnicity.  That post ...

XTI Aerospace (XTIA) announced the pricing of an underwritten public offering of 2,941,200 shares of its common stock and warrants to purchase ...

today announced the pricing of its initial public offering (the "Offering") of an aggregate of 2,100,000 ordinary shares of par value $0.00625 per share (the “Ordinary Shares”), at a public ...

Opus Genetics announces $20 million public offering and $1.5 million private placement for gene therapy development and operations. Opus Genetics, Inc., a clinical-stage biotechnology company ...

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the ...

Waton Financial Limited (“WTF” or the “Company”), a British Virgin Islands-incorporated holding company that provides of ...